1. A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony‐stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis. Issue 6 (20th October 2015) Authors: Iio, Etsuko; Ocho, Makoto; Togayachi, Akira; Nojima, Masanori; Kuno, Atsushi; Ikehara, Yuzuru; Hasegawa, Izumi; Yatsuhashi, Hiroshi; Yamasaki, Kazumi; Shimada, Noritomo; Ide, Tatsuya; Shinkai, Noboru; Nojiri, Shunske; Fujiwara, Kei; Joh, Takashi; Mizokami, Masashi; Narimatsu, Hisashi; Tanaka, Yas... Journal: International journal of cancer Issue: Volume 138:Issue 6(2016:Mar. 15) Page Start: 1462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus. Issue 3 (22nd September 2017) Authors: Inoue, Takako; Goto, Takaaki; Iio, Etsuko; Matsunami, Kayoko; Fujiwara, Kei; Shinkai, Noboru; Matsuura, Kentaro; Matsui, Takeshi; Nojiri, Shunsuke; Tanaka, Yasuhito Journal: Hepatology research Issue: Volume 48:Issue 3(2018) Page Start: E203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy. Issue 12 (6th May 2017) Authors: Iio, Etsuko; Shimada, Noritomo; Takaguchi, Koichi; Senoh, Tomonori; Eguchi, Yuichiro; Atsukawa, Masanori; Tsubota, Akihito; Abe, Hiroshi; Kato, Keizo; Kusakabe, Atsunori; Miyaki, Tomokatsu; Matsuura, Kentaro; Matsunami, Kayoko; Shinkai, Noboru; Fujiwara, Kei; Nojiri, Shunsuke; Tanaka, Yasuhito Journal: Hepatology research Issue: Volume 47:Issue 12(2017) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Factors associated with the effect of interferon‐α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B. Issue 12 (4th February 2015) Authors: Matsumoto, Akihiro; Yatsuhashi, Hiroshi; Nagaoka, Shinya; Suzuki, Yoshiyuki; Hosaka, Tetsuya; Tsuge, Masataka; Chayama, Kazuaki; Kanda, Tatsuo; Yokosuka, Osamu; Nishiguchi, Shuhei; Saito, Masaki; Miyase, Shiho; Kang, Jong‐Hon; Shinkai, Noboru; Tanaka, Yasuhito; Umemura, Takeji; Tanaka, Eiji Journal: Hepatology research Issue: Volume 45:Issue 12(2015:Dec.) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re‐evaluation of HBsAg seroclearance. (5th November 2015) Authors: Seto, Wai‐Kay; Tanaka, Yasuhito; Wong, Danny K.‐H.; Shinkai, Noboru; Cheung, Ka‐Shing; Liu, Kevin S.‐H.; Fung, James; Lai, Ching‐Lung; Yuen, Man‐Fung Journal: Liver international Issue: Volume 36:Number 5(2016) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Noninvasive evaluation of hepatic fibrosis in hepatitis C virus‐infected patients using ethoxybenzyl‐magnetic resonance imaging. Issue 6 (22nd May 2013) Authors: Nojiri, Shunsuke; Kusakabe, Atsunori; Fujiwara, Kei; Shinkai, Noboru; Matsuura, Kentaro; Iio, Etsuko; Miyaki, Tomokatsu; Joh, Takashi Journal: Journal of gastroenterology and hepatology Issue: Volume 28:Issue 6(2013:Jun.) Page Start: 1032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Novel monitoring of hepatitis B reactivation based on ultra‐high sensitive hepatitis B surface antigen assay. (29th January 2017) Authors: Shinkai, Noboru; Kusumoto, Shigeru; Murakami, Shuko; Ogawa, Shintaro; Ri, Masaki; Matsui, Tekeshi; Tamori, Akihiro; Toyoda, Hidenori; Ishida, Takashi; Iida, Shinsuke; Tanaka, Yasuhito Journal: Liver international Issue: Volume 37:Number 8(2017) Page Start: 1138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with HBeAg‐positive chronic hepatitis B. (5th January 2016) Authors: Chuaypen, Natthaya; Posuwan, Nawarat; Payungporn, Sunchai; Tanaka, Yasuhito; Shinkai, Noboru; Poovorawan, Yong; Tangkijvanich, Pisit Journal: Liver international Issue: Volume 36:Number 6(2016) Page Start: 827 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Serum interferon‐gamma‐inducible protein‐10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C. Issue 12 (17th February 2014) Authors: Matsuura, Kentaro; Watanabe, Tsunamasa; Iijima, Sayuki; Murakami, Shuko; Fujiwara, Kei; Orito, Etsuro; Iio, Etsuko; Endo, Mio; Kusakabe, Atsunori; Shinkai, Noboru; Miyaki, Tomokatsu; Nojiri, Shunsuke; Joh, Takashi; Tanaka, Yasuhito Journal: Hepatology research Issue: Volume 44:Issue 12(2014:Dec.) Page Start: 1208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗